CTRI Number |
CTRI/2015/02/005525 [Registered on: 11/02/2015] Trial Registered Retrospectively |
Last Modified On: |
03/12/2018 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Unani |
Study Design |
Single Arm Study |
Public Title of Study
|
To evaluate the Safety and efficacy of Unani formulation in the treatment of Palpitation |
Scientific Title of Study
|
Clinical Validation of Unani Pharmacopoeial Formulation – Dawa-ul-Misk Mutadil Sada in Khafaqan (Palpitation) |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
K/P/DMMS CLNVAL/CCRUM 13-14 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
PROF S SHAKIR JAMIL |
Designation |
DIRECTOR GENERAL |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
01128521981 |
Fax |
01128522965 |
Email |
unanimedicine@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DR K M SIDDIQUI |
Designation |
DEPUTY DIRECTOR |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
9810161758 |
Fax |
01128522965 |
Email |
ccrum507@gmail.com |
|
Details of Contact Person Public Query
|
Name |
DR PRADEEP KUMAR |
Designation |
RESEARCH OFFICER SCIENTIST III |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM) |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri
West DELHI 110058 India |
Phone |
01128521981 |
Fax |
01128522965 |
Email |
drpradeepkumar2001@gmail.com |
|
Source of Monetary or Material Support
|
Infrastructural support: 1.Central Research Institute of Unani Medicine (CRIUM), Hyderabad 2.Regional Research Institute of Unani Medicine (RRIUM), Aligarh 3.Clinical Research Unit (CRU), Bhurhanpur 4.Regional Research Centre (RRC), Allahabad
Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi |
|
Primary Sponsor
|
Name |
Central Council for Research in Unani MedicineCCRUM |
Address |
Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058. |
Type of Sponsor |
Research institution |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 4 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DR MUSHEER AHMAD KHAN |
Central Research Institute of Unani Medicine (CRIUM), Hyderabad |
AG Colony road, Erragadda, Hyderabad ANDHRA PRADESH |
04023810246
criumhyderabad@gmail.com |
DR SHAIKH NOOR MOHAMMAD |
Clinical Research Unit (CRU), Bhurhanpur |
Ganpati Naka Burhanpur West Nimar MADHYA PRADESH |
08109462242
mahajankk@rediffmail.com |
Dr Zubair Ahmad Khan |
Regional Research Centre (RRC), Allahabad |
B- 501/4, G.T.B. Nagar ( Opp. Dulhan Place) Allahabad Allahabad UTTAR PRADESH |
05322551808
rrcallahabad@gmail.com |
DR SHABANA PARVEEN |
Regional Research Institute of Unani Medicine (RRIUM), Aligarh |
Post Box 70, Near Head Post Office, Aligarh UTTAR PRADESH |
05712704781
rrium_aligarh@rediffmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 4 |
Name of Committee |
Approval Status |
Central Research Institute of Unani Medicine (CRIUM), Hyderabad |
Approved |
Clinical Research Unit (CRU), Bhurhanpur |
Approved |
Regional Research Centre (RRC), Allahabad |
Approved |
Regional Research Institute of Unani Medicine (RRIUM), Aligarh |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
Khafaqan (Palpitation), (1) ICD-10 Condition: R002||Palpitations, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Dawa-ul-Misk Motadil Sada |
Dawa-ul-Misk Motadil Sada, 5 gm, orally twice daily with water after meals for a period of 4 weeks |
Comparator Agent |
nil |
na |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
• Patients of either sex in the age group of 18-60
• Patients of Palpitation (heart rate: < 60 or >100 bpm) with and without any of the following symptoms/ signs:
ï‚§ Ghabrahat
ï‚§ Feeling of Missed Beat
ï‚§ Discomfort in Chest
ï‚§ Sweating
ï‚§ Dizziness
|
|
ExclusionCriteria |
Details |
• History of any heart diseases
• History of hepatic, renal disorders, diabetes mellitus, hypertension, anaemia, COPD
• History of thyroid dysfunction
• History of hypersensitivity to any ingredient of the study drug.
• Participants with history of long term use of any other drugs such as anti-epileptic, anti-arrhythmic and anti-psychotic drugs etc.
• History of Addiction (smoking, alcohol, drugs)
• Pregnant and lactating women
|
|
Method of Generating Random Sequence
|
|
Method of Concealment
|
|
Blinding/Masking
|
|
Primary Outcome
|
Outcome |
TimePoints |
Improvement in signs and symptoms |
4 weeks |
|
Secondary Outcome
|
Outcome |
TimePoints |
Hematological and biochemical assessments for safety |
4 weeks |
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
01/05/2014 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This study is designed as a multicentric open trial in patients with Khafaqan (Palpitation) After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be assessed clinically every
week. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 04 weeks. . Laboratory parameters for safety assessment will be conducted at baseline, first follow up and on completion of the protocol therapy.
Composition Dawa-ul-Misk Mutadil
Sada
Name
of ingredients Botanical/Zoological Name Quantity
1.
Zarishk (Berberis vulgaris) 50
gm
2. Tabasheer (Bambusa bambos) 30 gm
3. Sandal Safaid (Santalum album) 30 gm
4.
Sandal Surkh (Pterocarpus santalum) 30 gm
5.
Kishneez Khusk Muqashar (Coriandrum sativum) 30 gm
6. Gul-e-Gaozaban (Borago officinalis) 30
gm
7.
Aamla (Phylanthus emblica) 30 gm
8.
Tukhm-e-Khurfa (Portulaca oleracea) 30
gm
9.
Gul-e-Surkh (Rosa damascena) 20 gm
10.
Abresham (Bombax mori) 20 gm
11.
Darchini (Cinnamomum zeylanicum) 20 gm
12.
Bahaman Safaid (Centaurea behen) 20
gm
13.
Bahman Surkh (Savia
haematodes) 20 gm
14.
Darunaj Aqrabi (Doronicum hookrii) 20 gm
15.
Ood Hindi (Aquilaria agallocha) 15 gm
16.
Badranjboya (Melissa parviflora) 15 gm
17.
Mastagi (Pistacia lentiscus) 10 gm
18.
Ushna (Usnea longissima) 10 gm
19.
Dana Heel Khurd (Elettaria cardamomum) 10 gm
20.
Zafran (Crocus sativus) 10 gm
21.
Mushk (Moschcus moschiferus) 10 gm
22.
Ambar Ashhab (Ambra grasea) 5
gm
23.
Aab-e-Seb Sheerin (Malus domestica) 450 ml
24.
Asl (Apis mellifera) 450 gm
25.
Qand Safaid (Saccharum officinarum) 900 gm
|